last year researcher emerging discipline dynamic dna nanotechnology developed striking capability engineering pathway controlled hybridization cascade small conditional dna scdnas execute dynamic function autonomously performing interaction conformation change prescribed order mechanism powered enthalpy base pairing entropy mixing exploiting diverse design element effect assembly disassembly pathway control considerable effort invested exploring dynamic dna nanotechnology test tube comparatively little attention paid dynamic rna nanotechnology offer profound opportunity introducing synthetic regulatory link living cell organism envision small conditional rna scrnas interact change conformation transduce detection endogenous programmable input production biologically active programmable output recognized endogenous biological pathway scenario input control scope regulation output control target regulation scrna leveraging programmability conditionality create logical link two motivating example consider conventional rna interference rnai offer benefit programmability lack conditionality rnai mediated small interfering rna sirnas enables knockdown gene choice executing molecular logic silence gene sirnas constitutively active difficult confine silencing subset cell study top enable cell selective silencing envision scrnas mediate conditional rnaiâ corresponding molecular logic gene transcribed silence independent gene upon detection mrna input scrnas perform shape sequence transduction form dicer substrate processed dicer yield sirna output anti targeting independent mrna destruction scenario would silenced tissue expressed bottom several group made contribution toward still outstanding goal engineering scrnas perform shape sequence transduction implement conditional rnai endeavor previously developed five scrna mechanism conditional dicer substrate formation exploiting different combination design element presence full length mrna input buffer mechanism produced conditional response yielding order magnitude increase production dicer substrate targeting independent mrna appropriately dimensioning chemically modifying scrnas product signal transduction reactant intermediate efficiently processed recombinant dicer yielding sirna output anti broad term work demonstrated design element previously developed explored context dynamic dna nanotechnology could adapted dynamic rna nanotechnology providing molecular vocabulary pursuing regulatory goal simplest promising mechanism employed duplex scrna upon detecting mrna input produced shrna dicer substrate processed dicer yield sirna output anti scrna mechanism partially displaces toehold mediated way branch migration step exposing previously sequestered internal toehold within mediating way branch migration step promotes spontaneous dissociation yield shrna dicer substrate mechanism desirable property scrna stable rather metastable scrnas allowed equilibrate absence predominantly remain reactant state rather producing product shrna hence thermodynamic rather kinetic limit amount spurious output produced absence input providing conceptual basis engineering clean reliable state measured conditional response production shrna test tube state undetectable smaller gel quantification uncertainty illustrating benefit using stable scrna conditional response full length mrna input fold hand using short rna input corresponding portion mrna bind scrna ratio fold suggesting secondary structure full length mrna inhibited interaction scrna degree stepping stone toward validating scrna signal transduction living cell organism tested scrna mechanism human cell lysate compared previous test tube study buffer using recombinant dicer lysate functional endogenous dicer closely mimic cellular environment includes cellular protein nucleic acid inhibit scrna function rnase degrade scrnas specifically avoided adding rnase inhibitor lysate order preserve challenge overcoming rnase mediated degradation notably working lysate eliminates need deliver scrnas across cell membrane removing potential failure mode order focus attention performance signal transduction mechanism http pub ac org doi suppl acssynbio 8b00424 suppl_file sb8b00424_si_001 pdf http pub ac org doi suppl acssynbio 8b00424 suppl_file sb8b00424_si_001 pdf http pub ac org doi suppl acssynbio 8b00424 suppl_file sb8b00424_si_001 pdf http pub ac org doi suppl acssynbio 8b00424 suppl_file sb8b00424_si_001 pdf previous experiment performed using scrnas full length mrna input î¼m buffer assayed native polyacrylamide gel electrophoresis fluorescent staining previous rnai study suggest need sirna concentration range 15â within cell effective gene knockdown set test scrna lysate study provide sensitivity needed gel assay low concentration well discriminate scrna derived lysate derived nucleic acid radio labeled strand enabling tracking state change duplex scrna monomer shrna dicer substrate dicer processed sirna output anti rnase mediated degradation full length mrna input short rna input introduced scrna concentration scrnas low concentration buffer observed strong conditional production shrna response short rna input minimal response full length mrna input furthermore human cell lysate response short rna input substantially weakened negligible response full length mrna input initial failure provided embarkation point present work use human cell lysate engineering testbed optimize scrna performance full length mrna detection low concentration presence cellular protein nucleic acid rnase initial result suggested need redimension scrna sequence domain optimize energetics mechanism detection full length mrna input low concentration lysate several round sequence design experimental testing made following adjustment scrna increased toehold enhance nucleation better mediate subsequent partial opening duplex toehold mediated three way branch migration step increased duplex enhance self nucleation within better mediate subsequent opening duplex toehold mediated way branch migration step addition duplex require spontaneous dissociation reduce spurious production shrna absence input mrna design cycle new scrna domain dimension sequence design performed using reaction pathway designer within nupack sequence design formulated multistate optimization problem using target test tube represent reactant intermediate product state along reaction pathway target test tube contains depicted target complex corresponding pathway product given step depicted target structure target concentration well target complex complex four strand target concentration depicted corresponding pathway reactant pathway crosstalk given step sequence design performed subject complementarity constraint inherent reaction pathway domain complementary well biological sequence constraint imposed mrna input dsred2 mrna silencing target d2egfp current scrna mechanism every nucleotide design constrained subsequence either see constraint shading reflecting simplicity mechanism placing severe demand sequence design sequence optimized reducing ensemble defect quantifying average fraction incorrectly paired nucleotide multi tube ensemble optimization ensemble defect implement positive design paradigm explicitly designing pathway elementary step negative design paradigm explicitly designing pathway crosstalk ensemble defect decomposed two type contribution structural defectâ fraction nucleotide incorrect base pairing state within ensemble target complex concentration defectâ fraction nucleotide incorrect base pairing state deficiency concentration target complex display target test tube completed sequence design redimensioned scrna concentration defect negligible target complex form quantitative yield desired target concentration hand structural defect scrna see probability shading indicating undesired base pair toehold probability greater zero intermediate indicating desired base pair duplex probability le one defect reflect real world challenge designing sequence execute dynamic reaction pathway yet fully constrained sequence mrna operating human cell lysate redimensioned scrna exhibit strong conditional sirna production absence mrna input minimal production sirna output anti lane presence strong production anti lane verify sirna production dicer mediated depleted dicer lysate dicer knockdown cell using sirna pool followed lysate immunodepletion anti dicer antibody dicer depleted lysates show minimal sirna production lane relative wildtype lysates lane producing shrna instead sirna anti product signal transduction verify signal transduction triggered intended subsequence mrna input preincubated ²ome rna blocker strand bind nucleation site lane effectively blocking interaction restoring state lane http pub ac org doi suppl acssynbio 8b00424 suppl_file sb8b00424_si_001 pdf data demonstrate conditional sirna production forward molecular logic full length mrna input independent mrna silencing target intention demonstrating programmability scrna signal transduction repeated sequence design reverse molecular logic using mrna input mrna silencing target multiple sequence design ran difficulty designed scrnas functioned properly detecting short rna input targeted subsequence ineffective detecting full length mrna input see two example failure mode highlight inherent difficulty attempting engineer scrnas detect full length mrna rna secondary structure model underlying nupack accurate predicting structural property long mrna short scrnas presumably due combination pseudoknotting long range tertiary interaction lysate protein rna interactionsâ none accounted physical model effect sequence design pipeline succeeds engineering portion problem present model fails overcome challenge mrna structure omitted model http pub ac org doi suppl acssynbio 8b00424 suppl_file sb8b00424_si_001 pdf repeatedly encountering problem attempting engineer reverse logic came realize mrna accessibility major issue addressed experimentally preprocessing step prior sequence design measure base pairing accessibility directly developed simple cost effective method termed rnahybâ measure hybridization full length mrna individual labeled dna probe bind different subsequence along mrna see discovered window within mrna relatively inaccessible hybridization yield accessible region permit hybridization yield 20â using rnahyb identified window mrna relatively accessible well several shorter accessible window http pub ac org doi suppl acssynbio 8b00424 suppl_file sb8b00424_si_001 pdf interesting compare rnahyb probe hybridization yield nupack calculated subsequence free energy context full length mrna base pairing subsequence well within subsequence examining free energy subsequence represents simple computational proxy accessibility subsequence predicted inaccessible computationally large negative free energy observed poor binder experimentally subsequence predicted accessible computationally free energy near zero observed wide range binding strength experimentally reduce future experimental effort data suggest approach first computationally screening mrna subsequence identify promising candidate free energy near zero using rnahyb assay experimentally identify accessible window within reduced set subsequence study warranted contrast computational proxy mrna accessibility provide useful information http pub ac org doi suppl acssynbio 8b00424 suppl_file sb8b00424_si_001 pdf http pub ac org doi suppl acssynbio 8b00424 suppl_file sb8b00424_si_001 pdf http pub ac org doi suppl acssynbio 8b00424 suppl_file sb8b00424_si_001 pdf http pub ac org doi suppl acssynbio 8b00424 suppl_file sb8b00424_si_001 pdf http pub ac org doi suppl acssynbio 8b00424 suppl_file sb8b00424_si_001 pdf present case provided nupack rnahyb generated accessible window sequence constraint place full length mrna resulting nupack sequence design yielded scrna successfully detected full length mrna input however fixing mrna accessibility issue revealed new degradation issue functional scrna reverse logic rapidly degraded rnase lysate interestingly observed degradation issue nearly degree forward logic scrna point previous work forward logic used fully modified ²ome rna strand prevent dicer processing scrna unmodified strand permit dicer processing shrna output reverse logic found resistant degradation monomer shrna susceptible degradation part dimer scrna simultaneously prevent degradation maintain dicer cleavage shrna tested variety chemical modification including various subset ²ome rna nucleotide phosphorothioate backbone modification dna nucleotide conveniently discovered using ²ome rna cap either end strand conjunction ²ome rna strand yielded desired property reverse mechanism well forward mechanism leveraging mrna accessibility sequence constraint provided rnahyb combination new scrna chemical modification yielded reverse mechanism data shown scrna executes logic nearly characteristic initial mechanism state scrna produce minimal shrna lane sirna output anti lane state scrna incubated full length mrna produce shrna lane cleaved dicer sirna output anti lane blocking nucleation site mrna restores state lane demonstrating scrna signal transduction triggered intended subsequence mrna input programmability ability redesign scrnas interact mrna choice orthogonality ability engineer scrnas operate independently without crosstalk key conceptual goal dynamic rna nanotechnology property highlighted side side demonstration forward system reverse system system produce strong state presented cognate mrna input clean state presented wrong input even though scrnas constrained sequence quantification sirna output band forward reverse system reveals strong conditional response low crosstalk corresponding fold increase production sirna output response cognate noncognate full length mrna input long run working toward goal establishing technology development pipeline scrna signal transduction living organism starting functional goal programmable conditional regulation cell selective gene silencing gene activation cell death first step decide programmable input endogenous pathway leverage followed invention scrna signal transduction mechanism exploiting design element dynamic rna nanotechnology computational sequence design experimental validation increasingly complex experimental setting buffer cell lysate cell culture finally living organism established human cell lysate scrna testbed intermediate chemically pristine environment buffer test tube challenging compartmentalized setting living cell radioactive labeling scrna allowed use biologically relevant scrna concentration lysate containing cellular protein nucleic acid including rnase lysate environment enabled optimization domain dimension scrnas functional buffer nonfunctional lysate well optimization scrna chemical modification inhibit pathway degradation retaining pathway dicer processing design change likely also necessary probably sufficient scrnas functional living cell environment pathway interrogation much difficult http pub ac org doi suppl acssynbio 8b00424 suppl_file sb8b00424_si_001 pdf lysate offer key benefit eliminating need scrna delivery simplicity come drawback design challenge related cellular compartmentalization lost lysate dilution cellular component lysate decrease protein nucleic acid concentration cell estimated order magnitude limiting ability characterize target sequence effect likely also contributing inability detect cellular mrna input lysate spiked transcribed mrna input lysate mrna accessibility another important stumbling block limiting utility multiple scrnas performed intended signal transduction presented short rna input failed detect short sequence embedded full length mrna overcome difficulty developed rnahyb assay directly characterize accessible window within rna input preprocessing step prior sequence design automated scrna sequence design performed using nupack multistate designer subject biological sequence constraint well imposed dynamic scrna reaction pathway approach achieved conditional sirna production fold response human cell lysate forward molecular logical reverse molecular logic full length mrna result illustrate programmability conditionality make scrna signal transduction alluring goal challenge engineering delivering scrnas living organism overcome offer potential serve powerful new research tool leveraging diverse endogenous pathway including rnai crispr cas9 example conditional gene silencing gene transcribed silence independent gene would probe genetic necessity conditional gene activation gene transcribed activate independent gene would probe genetic sufficiency conditional cell death gene transcribed induce apoptosisâ would probe developmental compensation case conditional regulation would mediated scrnas interact change conformation transduce detection programmable input activation desired regulatory output function selecting transcript desired spatial temporal expression profile regulatory function could restricted desired cell type tissue organ within model organism shift conditional regulation different tissue developmental stage scrnas would reprogrammed recognize different input molecular logic would attractive therapeutic potential programmable disease marker downstream regulatory output chosen independent therapeutic pathway enabling selective treatment diseased cell research therapeutic potential dynamic rna nanotechnology scrna signal transduction merit significant engineering effort molecular programming synthetic biology research community dynamic rna nanotechnology programmable conditional regulation small conditional rna scrnas design element dynamic rna nanotechnology opportunity programmable conditional regulation scrna signal transduction molecular logic conventional rnai conditional rnai conceptual illustration conventional rnai silence tissue conditional rnai silence tissue expressed exerting spatiotemporal control regulation scrna mechanism implementing molecular logic scrna detects mrna input containing subsequence leading production shrna dicer substrate processed dicer produce sirna output anti targeting mrna silencing target containing subsequence scrna stable absence partially displaces toehold mediated way branch migration exposing previously sequestered internal toehold within step internal nucleation duplex within mediates internal way branch migration form duplex facilitating disassembly spontaneous dissociation short duplex step dicer processing resulting canonical shrna dicer substrate yield sirna output anti guide strand domain length rna strand denoted uppercase letter sequence domain denoted lowercase letter complementarity indicated asterisk internal radiolabel denoted dot strand chemical modification ²ome rna dashed backbone nucleotide computational scrna sequence design using nupack sequence design formulated multistate optimization problem using target test tube represent reactant intermediate product state along reaction pathway target test tube contains depicted target complex corresponding pathway product given step depicted target structure target concentration well target complex complex strand target concentration depicted corresponding pathway reactant pathway crosstalk given step intermediate tube step contains truncated version strand facilitate design self nucleation duplex every nucleotide design constrained sequence either mrna input dsred2 mrna silencing target d2egfp see domain shading analysis design quality design ensemble tube depict predicted concentration target structure target complex nucleotide shaded indicate probability adopting depicted base pairing state equilibrium design target predicted form quantitative yield target concentration negligible concentration defect nucleotide unwanted base pairing interaction non negligible structural defect nucleotide shaded dark red bar graph depict residual defect target complex tube blue shading structural defect component green shading concentration defect component negligible sequence design rna conditional sirna production scrna signal transduction human cell lysate forward molecular logic mrna input detected generate sirna output anti targeting mrna silencing reverse molecular logic mrna input detected generate sirna output anti targeting mrna silencing scrna signal transduction lysate hek 293t either dicer depleted wildtype containing endogenous dicer strand internally radiolabeled dot enable native page assay scrna mrna input spiked lysate state minimal production sirna output absence mrna input lane blocked state mrna input preincubated blocker strand bind scrna nucleation site mrna lane state strong production sirna output presence mrna input lane shrna provides control illustrating dicer processing generate sirna output lane sirna size marker lane mrna dsred2 mrna d2egfp rnahyb experimental determination mrna accessibility input d2egfp rnahyb fraction probe bound dna probe labeled mrna input total probe tested interval along mrna input identify accessible window engineering reverse logic mechanism comparison rnahyb fraction probe bound yield mean replicates panel mrna subsequence free energy calculated using nupack subsequence predicted negligible base pairing increasingly negative probability equilibrium base pairing increase calculation performed one mrna subsequence time signal transduction using orthogonal scrnas human cell lysate conditional sirna production presence cognate mrna input state noncognate mrna input state forward logic cognate mrna input sirna output anti noncognate mrna input reverse logic cognate mrna input sirna output anti noncognate mrna input wildtype lysate containing endogenous dicer quantification sirna output band panel ratio forward reverse scrnas normalized signal sirna signal total lane signal three replicate gel mrna dsred2 mrna d2egfp sequence design performed using reaction pathway designer within nupack oligonucleotides rna ²ome rna synthesized rnase free hplc purified idt target mrna transcribed cell lysates made sonication hek 293t cell dicer depleted lysates generated knocking dicer using sirna pool prior lysis dicer immunodepletion following lysis incorporated backbone enable discrimination scrna reactant intermediate product lysate nucleic acid well enable gel assay low concentration scrna page purified duplex scrna signal transduction tested incubating scrnas short rna input full length mrna input buffer î¼g î¼l lysate experiment blocked nucleation site mrna input preincubated blocker reaction separated native page imaged autoradiography rnahyb used assay mrna accessibility using labeled dna probe interval along mrna input